Evaluation of the use of therapeutic peptides for cancer treatment

Area of Science:

• Oncology
• Biochemistry
• Drug Development

Background:

• Cancer and cardiovascular disease are leading causes of death globally.
• Conventional cancer therapies face challenges like drug resistance and poor tumor selectivity.
• There is a critical need for novel therapeutic agents with improved efficacy and safety profiles.

Purpose of the Study:

• To review and compare strategies for overcoming limitations of therapeutic peptides.
• To evaluate the potential of short cell-permeable peptides in cancer treatment.
• To enhance the therapeutic effect and applicability of peptide-based drugs.

Main Methods:

• Literature review of current strategies for peptide modification.
• Analysis of methods to improve peptide stability and half-life.
• Evaluation of cell-permeable peptides targeting protein-protein interactions.

Main Results:

• Therapeutic peptides present advantages such as ease of synthesis, high target specificity, and low toxicity.
• Key drawbacks include limited stability and short in vivo half-life.
• Strategies exist to enhance peptide stability and therapeutic outcomes.

Conclusions:

• Therapeutic peptides represent a viable and promising approach for cancer treatment.
• Overcoming peptide limitations is crucial for their clinical success.
• Targeting protein-protein interactions with peptides offers a novel therapeutic avenue.